p38 may be considered a tumor suppressor, however, some studies also provide evidence for an oncogenic potential related to its pro-inflammatory properties, capacity to regulate epithelial-mesenchymal transition, and angiogenesis [82,83,84,85]. The gene discussed is MAPK1; the disease is neoplasm.